Oxidative Stress in Neurodegeneration & Neuroprotection in Glaucoma
神经退行性变中的氧化应激
基本信息
- 批准号:9042368
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AmericanAnimal ModelAnimalsAntioxidantsAxonBlindnessCause of DeathCell Culture TechniquesDataDiseaseDisease ProgressionDrug Delivery SystemsEnzyme-Linked Immunosorbent AssayEventExperimental ModelsEyeFunctional disorderGlaucomaGoalsHealthHumanHydroxyl RadicalImageImmuneImmune System and Related DisordersImplantIn VitroInflammatory ResponseInfusion proceduresInjection of therapeutic agentInjuryMatched GroupMeasuresMediatingMethodologyMicrospheresModificationMolecularMusNerve DegenerationNerve Tissue ProteinsNeurodegenerative DisordersNeuronal InjuryNeuronsOcular HypertensionOptic NerveOutcomeOxidantsOxidation-ReductionOxidative StressPatientsPeroxonitritePhysiologic Intraocular PressurePost-Translational Protein ProcessingPredispositionProcessPumpRetinaRetinal Ganglion CellsSalineSampling BiasesStressSuperoxidesTechniquesTestingTimeVisionWestern BlottingWild Type Mouseanterior chamberbasecopingevent cycleimprovedin vivomouse modelneuroinflammationneuron lossneuronal cell bodyneuroprotectionneurotoxicitynormotensivepreventprimary outcomeresearch studyresponsesuperoxide dismutase 1tempoltranscription factortreatment effecttreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Our recent studies of human glaucoma and in vivo and in vitro experimental models collectively support that oxidative stress is a major component of cellular events during glaucomatous neurodegeneration. We hypothesize based on the findings of these studies that (1) oxidative stress reduces the ability of retinal ganglion cells (RGCs) and axons to cope with the elevated intraocular pressure (IOP)-related stress in glaucoma and facilitates neurodegenerative injury (by generating direct neurotoxicity and also secondary neurodegenerative consequences, such as glial dysfunction and neuroinflammation); and (2) by suppressing or eliminating the harmful consequences of oxidative stress, antioxidant treatment can protect against neurodegenerative injury. Proposed project will test the validity of this hypothesis in a mouse model of glaucoma with experimentally induced ocular hypertension by anterior chamber microbead/viscoelastic injections in one eye. We will use two experimental paradigms to analyze the temporal effects of increased or decreased oxidative stress on glaucomatous neuronal injury. In the first experimental paradigm, we will analyze the effects of "deficient antioxidant response" on neuronal injury in experimentally induced glaucoma in superoxide dismutase 1 (SOD1)-/- versus C57BL/6J (wild-type) mice. This analysis will determine whether overloaded oxidative stress in SOD1-/- mice increases the susceptibility to neuronal injury in experimental glaucoma. In the second experimental paradigm, we will analyze the effects of a pharmacological "antioxidant treatment" on neuronal injury in wild-type mice with experimental glaucoma. Animals will receive Tempol (an antioxidant protecting against multiple oxidants, such as superoxide, peroxynitrite, and hydroxyl radicals) or vehicle (saline) using subcutaneously implanted osmotic mini-pumps for drug delivery by constant infusion. This analysis will determine whether pharmacological inhibition of oxidative stress acts to break the cycle of events leading to neurodegenerative injury, and whether antioxidant treatment has any potential as a neuroprotective strategy for glaucoma. We will determine neuronal injury by counting RGC axons and somas in their entirety using an imaging-based improved methodology free from sampling bias. We will also determine SOD1-/- and Tempol effects on oxidative stress-related major molecular outcomes of glaucoma, including retina and optic nerve protein carbonyl and HNE levels reflecting oxidative modifications and a "redox- sensitive" transcription factor, NF-κB that regulates glial immune/inflammatory responses in glaucoma. The data will be statistically compared between experimental groups matched for the cumulative IOP exposure (and axon loss within each group) at different time points during an experimental period of up to 12 weeks. This project is expected to determine the pathogenic importance of oxidative stress for glaucomatous neurodegeneration and the potential of antioxidant treatment as a neuroprotection strategy in glaucoma. The new information will also have broad implications useful for other ocular and neurodegenerative diseases.
描述(由申请人提供):我们最近对人类青光眼以及体内和体外实验模型的研究共同支持氧化应激是青光眼神经变性期间细胞事件的主要组成部分。基于这些研究结果,我们假设:(1)氧化应激降低了青光眼视网膜神经节细胞(RGCs)和轴突应对眼压升高(IOP)相关应激的能力,并促进神经退行性损伤(通过产生直接的神经毒性和继发性神经退行性后果,如神经胶质功能障碍和神经炎症);(2)通过抑制或消除氧化应激的有害后果,抗氧化治疗可以防止神经退行性损伤。拟建项目将通过单眼前房微珠/粘弹性注射实验性高眼压青光眼小鼠模型验证这一假说的有效性。我们将使用两种实验范式来分析氧化应激增加或减少对青光眼神经元损伤的时间效应。在第一个实验范式中,我们将分析“缺乏抗氧化反应”对超氧化物歧化酶1 (SOD1)-/-与C57BL/6J(野生型)小鼠实验诱导的青光眼神经元损伤的影响。该分析将确定SOD1-/-小鼠过度氧化应激是否会增加实验性青光眼神经元损伤的易感性。在第二个实验范式中,我们将分析药理学“抗氧化治疗”对实验性青光眼野生型小鼠神经元损伤的影响。动物将接受Tempol(一种抗氧化剂,可抵抗多种氧化剂,如超氧化物、过氧亚硝酸盐和羟基自由基)或载体(生理盐水),通过皮下植入渗透性微型泵,通过持续输注给药。该分析将确定氧化应激的药理抑制是否能打破导致神经退行性损伤的事件循环,以及抗氧化治疗是否有可能作为青光眼的神经保护策略。我们将使用基于成像的改进方法,通过对RGC轴突和体细胞的整体计数来确定神经元损伤。我们还将确定SOD1-/-和Tempol对青光眼氧化应激相关主要分子结局的影响,包括反映氧化修饰的视网膜和视神经蛋白羰基和HNE水平,以及调节青光眼胶质免疫/炎症反应的“氧化还原敏感”转录因子NF-κ b。数据将在长达12周的实验期间,在不同时间点进行累积IOP暴露(以及每组内轴突损失)匹配的实验组之间进行统计比较。该项目旨在确定氧化应激对青光眼神经变性的致病重要性,以及抗氧化治疗作为青光眼神经保护策略的潜力。新的信息也将对其他眼部和神经退行性疾病有广泛的意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gulgun TEZEL其他文献
Gulgun TEZEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gulgun TEZEL', 18)}}的其他基金
Regulation of Glia-driven Neuroinflammation in Glaucoma
青光眼中神经胶质细胞驱动的神经炎症的调节
- 批准号:
9910408 - 财政年份:2018
- 资助金额:
$ 20万 - 项目类别:
Proteomic Analysis of Retinal Ganglion Cell Death in Glaucoma
青光眼视网膜神经节细胞死亡的蛋白质组学分析
- 批准号:
7373784 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
Proteomic Analysis of Retinal Ganglion Cell Death in Glaucoma
青光眼视网膜神经节细胞死亡的蛋白质组学分析
- 批准号:
7531028 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
Proteomic Analysis of Retinal Ganglion Cell Death in Glaucoma
青光眼视网膜神经节细胞死亡的蛋白质组学分析
- 批准号:
7741650 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
TNF-alpha in cell death & neuroprotection in glaucoma
TNF-α在细胞死亡中的作用
- 批准号:
7100119 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
TNF-alpha in cell death & neuroprotection in glaucoma
TNF-α在细胞死亡中的作用
- 批准号:
6616471 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
TNF-alpha in Cell Death & Neuroprotection in Glaucoma
TNF-α 与细胞死亡
- 批准号:
7882346 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
TNF-alpha in cell death & neuroprotection in glaucoma
TNF-α在细胞死亡中的作用
- 批准号:
6784229 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




